Endo International Plc - Company Profile

Powered by

All the data and insights you need on Endo International Plc in one report.

  • Save hours of research time and resources with
    our up-to-date Endo International Plc Strategy Report

  • Understand Endo International Plc position in the market,
    performance and strategic initiatives.

  • Gain competitive edge and increase your
    chances of success

Back to companies

Endo International Plc: Executives

The following section provides information on Endo International Plc’s senior management, executives, CEO and key decision makers and their roles in the organization. For more insight into Endo International Plc's management and employees, unlock the full data with our company analytics monitoring tool.

Executives

Mark G. Barberio

Chairman; Director Executive Board Since: 2021

Mr. Mark G. Barberio has been the chairman of the board of directors of Endo since June 2021. He was appointed as a member of the board in February 2020. Prior to joining Endo, he held various leadership roles at Mark IV LLC. Currently, he is also a board member for Gibralter Industries and Life Storage Inc. Previously, Mr Barberio served as the director of Paragon Offshore and Exide Technologies.

Read Hide full bio of Mark G. Barberio

Blaise Coleman

President; Director; Chief Executive Officer Executive Board Since: 2020 Age: 49

Mr. Blaise Coleman has been the Chief Executive Officer, President and Director of the company since March 2020. Previously, he served as the Chief Financial Officer and Executive Vice President of the company since 2016. Prior to this, he served as the Senior Vice President, Global Finance Operations of the company. Mr. Coleman also served as the Vice President of Corporate Financial Planning & Analysis of Endo, the Chief Financial Officer of the AstraZeneca/Bristol-Myers Squibb US Diabetes Alliance and Head of Finance for the AstraZeneca Global Medicines Development organization in Sweden. He has been the Senior Director Commercial Finance for AstraZeneca's US Cardiovascular Business in 2007.

Read Hide full bio of Blaise Coleman

Mark Bradley

Executive Vice President; Chief Financial Officer Senior Management Since: 2020 Age: 54

Mr. Mark Bradley has been the Executive Vice President and the Chief Financial Officer of the company since March 2020. Previously, he served as the Senior Vice President, Corporate Development and Treasurer of the company and also served as the Finance Director of the company. Before joining Endo, he served in companies such as Deloitte Consulting, Ernst & Young LLP.

Read Hide full bio of Mark Bradley

Cheryl Stouch

Chief Information Officer; Senior Vice President - Information Technology Senior Management Since: 2022

Ms. Cheryl Stouch has been the Chief Information Officer and Senior Vice President of Information Technology of the company since 2022. Prior to this, she served as the Executive Director of IT Corporate Functions & End User Services at Endo. Previously, she also served in various roles at Shire.

Read Hide full bio of Cheryl Stouch

Susan Williamson

Chief Compliance Officer; Senior Vice President Senior Management Since: 2018

Ms. Susan Williamson has been the Senior Vice President and the Chief Compliance Officer of the company since April 2018. Previously, she served as Endo's Vice President and U.S. and Canadian Compliance Officer. Prior to this, she served at Pfizer, Wyeth Pharmaceuticals and at Ernst & Young.

Read Hide full bio of Susan Williamson
Gain a 360-degree view of Endo International Plc and make more informed decisions for your business Gain a 360-degree view of Endo International Plc and make more informed decisions for your business Find out more
Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer

Start of HubSpot Embed Code End of HubSpot Embed Code